<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
63323-344-10
</NDCCode>
<PackageDescription>
25 VIAL in 1 TRAY (63323-344-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
</PackageDescription>
<NDC11Code>
63323-0344-10
</NDC11Code>
<ProductNDC>
63323-344
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Ceftriaxone
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ceftriaxone Sodium
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, FOR SOLUTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR; INTRAVENOUS
</RouteName>
<StartMarketingDate>
20060308
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA065245
</ApplicationNumber>
<LabelerName>
APP Pharmaceuticals, LLC
</LabelerName>
<SubstanceName>
CEFTRIAXONE SODIUM
</SubstanceName>
<StrengthNumber>
250
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-09-05
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>